NCT00005574View on ClinicalTrials.gov

Gentamicin Treatment of Muscular Dystrophy

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

February 29, 2000

Study Completion Date

January 31, 2001

Conditions
Becker Muscular DystrophyDuchenne Muscular Dystrophy
Interventions
DRUG

Gentamicin

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00005574 - Gentamicin Treatment of Muscular Dystrophy | Biotech Hunter | Biotech Hunter